# OnCo record instituto-alexander-fleming (institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/institutions/instituto-alexander-fleming/>
  a schema:MedicalOrganization ;
  onco:kind "institution" ;
  schema:identifier "instituto-alexander-fleming" ;
  schema:name "Instituto Alexander Fleming"@en ;
  schema:alternateName "IAF"@en, "Fleming"@en ;
  schema:description "The Instituto Alexander Fleming in Buenos Aires, founded in 1994, is Argentina's most research-active cancer centre; it has enrolled Argentine patients in the pivotal HER2, CDK4/6, lung and colorectal trials of the last three decades and hosts the GAICO cooperative group."@en ;
  schema:url <https://onco.cc/institutions/instituto-alexander-fleming/>, <https://www.alexanderfleming.org> ;
  schema:dateModified "2026-09-09"^^xsd:date ;
  schema:citation <https://www.alexanderfleming.org> ;
  schema:addressCountry "AR" ;
  schema:addressLocality "Buenos Aires" ;
  schema:latitude "-34.552"^^xsd:decimal ;
  schema:longitude "-58.452"^^xsd:decimal ;
  onco:cancers <https://onco.cc/cancers/breast-her2-positive/>, <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/colorectal/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> ;
  onco:technologies <https://onco.cc/technologies/cgp/> ;
  onco:targets <https://onco.cc/targets/her2/>, <https://onco.cc/targets/cdk4-6/> ;
  onco:drugs <https://onco.cc/drugs/trastuzumab/>, <https://onco.cc/drugs/palbociclib/> ;
  onco:people <https://onco.cc/people/bernardo-rubinstein/> .